Table 1.

Correlation between CD163 expression and clinicopathological features of breast cancer

Characteristics	CD163high		CD163low		p value
	N	%	N	%
	43	40.9%	62	59.1%
Age
< 50 (years)	19	44.2%	23	37.1%	0.537
> 50 (years)	24	55.8%	39	62.9%
TNM stage
I	11	25.6%	18	29%	0.118
II	12	27.9%	29	46.8%
III–IV	20	46.5%	15	24.2%
Lymph node metastasis
Negative	13	30.2%	28	45.2%	0.012
Positive	30	69.8%	34	54.8%